RBM15-MKL1融合蛋白通过m6A甲基化和WNT通路激活促进白血病
bioRxiv : the preprint server for biology
|March 10, 2025
概括
由RBM15-MKL1 (RM) 驱动的急性巨核细胞白血病 (AMKL) 依赖于N6-甲基氨酸 (m6A) 修饰. 抑制METTL3,一个m6A编写器,通过影响Wnt信号和Frizzled基因表达来准RM-AMKL.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 由RBM15-MKL1 (RM) 融合蛋白驱动的急性巨核细胞白血病 (AMKL) 与N6-甲基氨酸 (m6A) 编写复合体有关.
- m6A修饰的失调与瘤发生有关,METTL3抑制显示出抗瘤活性,但机制尚不清楚.
研究的目的:
- 调查m6A修饰在RM-AMKL病变发生中的作用.
- 阐明m6A对白血病发生的作用机制.
- 为了确定RM-AMKL的潜在治疗点.
主要方法:
- 用一种新型METTL3抑制剂 (STM3675) 治疗小鼠RM-AMKL细胞.
- 多原子方法结合了对RNA结合,甲基化和周转的全转录组评估.
- 对Wnt信号通路组件的分析,包括Frizzled基因和β-catenin.
主要成果:
- 在RM-AMKL细胞中,METTL3抑制诱导了亡,在小鼠中延长了生存时间.
- RM保留了RBM15的RNA结合和m6A修饰功能,选择性地调节像Frizzled这样的Wnt信号基因.
- 在RM-AMKL中,Frizzled基因上调是m6A依赖的,对白血病生长至关重要.
结论:
- m6A修改和Wnt信号激活是RM-AMKL的关键驱动因素.
- 抑制METTL3代表了RM-AMKL的潜在治疗策略.
- 针对Wnt信号通路可能有利于RM-AMKL治疗.
相关概念视频
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Master Transcription Regulators
6.8K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.8K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
Canonical Wnt Signaling Pathway
8.6K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.6K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K


